89bio Historical Financial Ratios
| ETNB Stock | USD 8.08 0.06 0.75% |
89bio is presently reporting on over 94 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 2.15 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate 89bio Inc financial condition quickly.
89bio |
About 89bio Financial Ratios Analysis
89bio IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate 89bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on 89bio financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across 89bio history.
89bio Financial Ratios Chart
Add Fundamental
Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Income Quality
An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.Most ratios from 89bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into 89bio Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, 89bio's PTB Ratio is projected to increase based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 4.52, whereas Free Cash Flow Yield is projected to grow to (0.43).
89bio fundamentals Correlations
Click cells to compare fundamentals
89bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
89bio fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 1.93 | 2.09 | 2.92 | 1.48 | 2.04 | 2.15 | |
| Book Value Per Share | 12.62 | 6.27 | 4.36 | 7.54 | 3.83 | 4.52 | |
| Free Cash Flow Yield | (0.12) | (0.29) | (0.18) | (0.16) | (0.45) | (0.43) | |
| Operating Cash Flow Per Share | (2.87) | (3.82) | (2.33) | (1.82) | (3.51) | (3.69) | |
| Capex To Depreciation | 2.1 | 0.8 | 0.11 | 0.08 | (0.001641) | (0.001559) | |
| Pb Ratio | 1.93 | 2.09 | 2.92 | 1.48 | 2.04 | 2.15 | |
| Free Cash Flow Per Share | (2.88) | (3.82) | (2.33) | (1.82) | (3.51) | (3.69) | |
| Roic | (0.24) | (0.62) | 0.59 | (0.27) | (0.86) | (0.82) | |
| Net Income Per Share | (3.08) | (4.48) | (2.93) | (2.0) | (3.51) | (3.68) | |
| Payables Turnover | 0.0291 | 0.0115 | 0.0192 | 0.0318 | 0.0286 | 0.015 | |
| Cash Per Share | 19.34 | 12.39 | 5.41 | 8.13 | 4.2 | 3.99 | |
| Pocfratio | (8.48) | (3.42) | (5.46) | (6.15) | (2.23) | (2.34) | |
| Capex To Operating Cash Flow | (0.002725) | (8.21E-4) | (8.6E-5) | (3.1E-5) | (4.1E-5) | (4.3E-5) | |
| Pfcf Ratio | (8.46) | (3.42) | (5.46) | (6.15) | (2.23) | (2.34) | |
| Days Payables Outstanding | 12.6K | 31.6K | 19.0K | 11.5K | 13.2K | 12.5K | |
| Income Quality | 0.93 | 0.85 | 0.79 | 0.91 | 1.0 | 0.66 | |
| Roe | (0.24) | (0.72) | (0.67) | (0.27) | (0.92) | (0.87) | |
| Ev To Operating Cash Flow | (4.05) | (1.71) | (5.03) | (3.92) | (1.89) | (1.98) | |
| Pe Ratio | (7.92) | (2.91) | (4.34) | (5.59) | (2.23) | (2.34) | |
| Return On Tangible Assets | (0.23) | (0.55) | (0.52) | (0.24) | (0.77) | (0.81) | |
| Ev To Free Cash Flow | (4.04) | (1.71) | (5.03) | (3.92) | (1.89) | (1.98) | |
| Earnings Yield | (0.13) | (0.34) | (0.23) | (0.18) | (0.45) | (0.47) | |
| Net Debt To E B I T D A | 4.13 | 1.46 | 0.35 | 2.15 | 0.32 | 0.31 | |
| Current Ratio | 25.91 | 8.29 | 7.97 | 20.04 | 13.19 | 10.86 | |
| Tangible Book Value Per Share | 12.62 | 6.27 | 4.36 | 7.54 | 3.83 | 4.52 | |
| Shareholders Equity Per Share | 12.62 | 6.27 | 4.36 | 7.54 | 3.83 | 4.52 | |
| Capex Per Share | 0.007832 | 0.003135 | 2.01E-4 | 5.6E-5 | 1.43E-4 | 1.36E-4 | |
| Graham Net Net | 18.83 | 10.58 | 4.11 | 7.29 | 3.46 | 5.6 | |
| Enterprise Value Over E B I T D A | (3.79) | (1.46) | (4.09) | (3.76) | (1.81) | (1.9) | |
| Price Earnings Ratio | (7.92) | (2.91) | (4.34) | (5.59) | (2.23) | (2.34) | |
| Price Book Value Ratio | 1.93 | 2.09 | 2.92 | 1.48 | 2.04 | 2.15 | |
| Days Of Payables Outstanding | 12.6K | 31.6K | 19.0K | 11.5K | 13.2K | 12.5K | |
| Price To Operating Cash Flows Ratio | (8.48) | (3.42) | (5.46) | (6.15) | (2.23) | (2.34) | |
| Price To Free Cash Flows Ratio | (8.46) | (3.42) | (5.46) | (6.15) | (2.23) | (2.34) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.